Lunit, a leading company in AI technology for cancer diagnosis and treatment, has been chosen as the sole AI partner for the breast cancer screening program in Spain’s Valencian Community. This region has about 5 million people and is the third largest and fourth most economically strong area in Spain. It is known for its progressive healthcare system and has been a leader in adopting digital health innovations, AI diagnostics, and biomedical advancements within its public health services.
Health Technology Insights: Corewell, Quest Partner to Expand Lab Services in Michigan
In 2024, the region started looking for AI solutions to improve its organized breast cancer screening program. The aim is to increase the number of women participating each year from 250,000 to 400,000 while maintaining high care standards. After thoroughly reviewing several AI providers based on scientific value, ease of integration, and clinical effectiveness, Lunit’s tools were selected for their ability to simplify processes and help radiologists provide quicker, more accurate diagnoses.
Health Technology Insights: Health Technology Insights: Latest News And Innovations – Roundup 26 August 2025
The agreement involves using Lunit’s INSIGHT MMG and INSIGHT DBT technologies across the entire Valencian Community, marking Lunit’s largest project in Europe to date. Brandon Suh, CEO of Lunit, stressed the importance of this partnership, pointing out that the Valencian Community’s decision shows a growing trend where AI is seen as a real solution to current healthcare issues rather than just a future possibility. He added that by working with this forward-thinking healthcare authority, Lunit aims to improve efficiency and help set new standards for widely accessible and effective cancer screening.
The Valencian Community is now part of a list of global regions including Iceland, Australia, Singapore, Saudi Arabia, Qatar, and the UAE where Lunit’s AI technology supports public breast screening programs.
In addition to implementation, Lunit and the Valencian Community have committed to ongoing scientific research to develop new methods for early cancer detection and enhance population health outcomes.
Health Technology Insights: Leal Therapeutics Raises $30Million for Neuro-Metabolic Therapies
To participate in our interviews, please write to our HealthTech Media Room at sudipto@intentamplify.com
